Arkadios Wealth Advisors Acquires New Stake in Silicon Laboratories Inc. (NASDAQ:SLAB)

Arkadios Wealth Advisors purchased a new position in shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 1,911 shares of the semiconductor company's stock, valued at approximately $237,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Envestnet Asset Management Inc. increased its position in Silicon Laboratories by 15.6% during the second quarter. Envestnet Asset Management Inc. now owns 110,375 shares of the semiconductor company's stock worth $12,211,000 after buying an additional 14,877 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Silicon Laboratories by 2.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 639,065 shares of the semiconductor company's stock worth $70,699,000 after acquiring an additional 12,680 shares during the last quarter. Vanguard Personalized Indexing Management LLC raised its stake in Silicon Laboratories by 39.0% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 3,222 shares of the semiconductor company's stock valued at $356,000 after acquiring an additional 904 shares during the period. Hsbc Holdings PLC lifted its holdings in Silicon Laboratories by 470.5% during the 2nd quarter. Hsbc Holdings PLC now owns 28,267 shares of the semiconductor company's stock valued at $3,109,000 after purchasing an additional 23,312 shares during the last quarter. Finally, XTX Topco Ltd bought a new position in Silicon Laboratories during the second quarter worth $212,000.

Insider Buying and Selling at Silicon Laboratories

In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of the firm's stock in a transaction that occurred on Wednesday, January 22nd. The shares were sold at an average price of $140.77, for a total value of $281,540.00. Following the sale, the director now owns 32,115 shares in the company, valued at $4,520,828.55. This trade represents a 5.86 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Company insiders own 1.72% of the company's stock.

Silicon Laboratories Trading Down 4.2 %

SLAB stock traded down $5.94 during mid-day trading on Friday, hitting $135.58. The stock had a trading volume of 141,472 shares, compared to its average volume of 295,251. The firm has a fifty day simple moving average of $122.62 and a 200 day simple moving average of $115.61. Silicon Laboratories Inc. has a 52 week low of $94.00 and a 52 week high of $154.91. The firm has a market capitalization of $4.40 billion, a P/E ratio of -18.30 and a beta of 1.17.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.07. Silicon Laboratories had a negative net margin of 46.93% and a negative return on equity of 12.60%. The business had revenue of $166.00 million during the quarter, compared to the consensus estimate of $165.50 million. During the same period in the previous year, the business earned $0.48 earnings per share. The company's revenue was down 18.5% on a year-over-year basis. As a group, equities analysts expect that Silicon Laboratories Inc. will post -3.56 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on SLAB. JPMorgan Chase & Co. cut their target price on shares of Silicon Laboratories from $150.00 to $135.00 and set an "overweight" rating for the company in a research note on Tuesday, November 5th. Susquehanna began coverage on Silicon Laboratories in a report on Tuesday, December 17th. They set a "neutral" rating and a $130.00 price objective for the company. KeyCorp increased their target price on Silicon Laboratories from $115.00 to $160.00 and gave the stock an "overweight" rating in a research note on Wednesday. Morgan Stanley reduced their price target on Silicon Laboratories from $123.00 to $97.00 and set an "equal weight" rating for the company in a research note on Tuesday, November 5th. Finally, Benchmark reiterated a "hold" rating on shares of Silicon Laboratories in a research report on Tuesday, November 5th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $133.56.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.